Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mathieu Charvériat

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

Fundamental & clinical pharmacology

Assay and drug development technologies

SLAS discovery : advancing life sciences R & D

Scientific reports

Mines ParisTech (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Mines ParisTech

France

MSC

Publications

Julie Bigarreau, Nathalie Rouach, Anselme L Perrier, Franck Mouthon, Mathieu Charvériat
Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models. International journal of molecular sciences 23 (3) (2022)
Jean-Luc Cracowski, Jean-Sébastien Hulot, Silvy Laporte, Mathieu Charvériat, Matthieu Roustit, Dominique Deplanque, Pierre-Olivier Girodet, null null
Clinical pharmacology: Current innovations and future challenges. Fundamental & clinical pharmacology 36 (3) (2022)
Anaelle da Costa, Christèle Picoli, Franck Mouthon, Mathieu Charvériat
Automated Assays to Identify Modulators of Transcription Factor EB Translocation and Autophagy. Assay and drug development technologies 20 (2) (2021)
Mathieu Charvériat, Stephan J Darmoni, Vincent Lafon, Nicholas Moore, Régis Bordet, Julien Veys, Franck Mouthon, null null
Use of real-world evidence in translational pharmacology research. Fundamental & clinical pharmacology (2021)
Emmanuelle Soleilhac, Marjorie Comte, Anaelle da Costa, Caroline Barette, Christèle Picoli, Magda Mortier, Laurence Aubry, Franck Mouthon, Marie-Odile Fauvarque, Mathieu Charvériat
Quantitative Automated Assays in Living Cells to Screen for Inhibitors of Hemichannel Function. SLAS discovery : advancing life sciences R & D 26 (3) (2020)
Anaelle da Costa, Thibaud Metais, Franck Mouthon, Danielle Kerkovich, Mathieu Charvériat
Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders. Fundamental & clinical pharmacology 35 (3) (2020)
Marine Droguerre, Tomokazu Tsurugizawa, Adeline Duchêne, Benjamin Portal, Bruno P Guiard, Nicole Déglon, Nathalie Rouach, Michel Hamon, Franck Mouthon, Luisa Ciobanu, Mathieu Charvériat
A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain. Scientific reports 9 (1) (2019)
Fabien Sauvet, Mégane Erblang, Danielle Gomez-Merino, Arnaud Rabat, Mathias Guillard, Dominique Dubourdieu, Hervé Lefloch, Catherine Drogou, Pascal Van Beers, Clément Bougard, Cyprien Bourrrilhon, Pierrick Arnal, Werner Rein, Franck Mouthon, Francoise Brunner-Ferber, Damien Leger, Yves Dauvilliers, Mounir Chennaoui, Mathieu Charvériat
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target. British journal of clinical pharmacology 85 (11) (2019)

Mathieu Charvériat.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mathieu Charvériat